期刊文献+

卵巢癌细胞在血液循环中的微转移 被引量:4

CIRCULATING CELL MICROMETASTASES OF OVARY CANCER
原文传递
导出
摘要 目的 :了解卵巢癌患者除直接侵袭或植入体腔外 ,是否还通过血液循环的渠道而转移。方法 :以角蛋白19(K- 19) - m RNA及癌胚抗原 (CEA) - m RNA两基因的表达为标记物 ;应用巢式—反转录聚合酶链反应 (Nested-RT- PCR)进行扩增 ,经 PAGE后进行观察。结果 :5 1例卵巢癌的骨髓标本中 2 1例 (4 1.18%) K- 19为阳性 ,CEA阳性 4例 (7.84%) ,双阳性 5例 (9.8%) ;K- 19加双项阳性为 2 6例 (5 0 .98%) ,阴性 2 1例 (4 1.2 %)。 2 2例周围血中 K-19阳性 3例 (13.6 3%)、CEA1例 (4 .5 5 %) ,无双阳性 ,阴性 18例 (81.82 %)。经 χ2分析患者骨髓标本结果与正常对照间有显著性差异 (P<0 .0 0 5 ) ,而患者周围血与对照组间则无明显差异 (P>0 .0 5 )。临床分期之早晚及年龄之增长 ,其阳性率有上升趋势。病理型态之恶性程度高者微转移率较恶性程度低者为高。结论 :以 Nested- RT- PCR对 K-19- m RNA表达的检测来判断卵巢癌的微转移是一种很灵敏的方法 ,凡阳性者必须及早采用较长时间化疗 。 Objective:To define if the circulating metastases is another rout beside invasion and planting in body cavity of ovary cancer patients.Methods:Nested reverse transcription polymerase chain reaction (Nested RT PCR) was employed to examine the expression of Keratin 19(K 19) and Carcinoembryonic antigen (CEA) mRNA with bone marrow (BM) aspirates specimens.Results:Of the BM specimen in 51 cases of ovary cancer patients,21(41.18%) K 19 and 4(7.84%) CEA were positive,5(9.8%) were double positive,K 19 plus double positive were 26(50.98%),negative were 21(41.2%).Of the 22 patients′peripheral blood (PB) samples,3 cases (13.63%) K 19 and 1 case (4.55%) CEA were positive,no double positive,and 18 cases (81.82%) were negative.Analysis by statistical method (χ 2) showed significant difference between BM and PB or control samples ( P <0.005),while there was no difference between PB sample and control ( P >0.05).The positive rate increased according to the progressing of clinical stages,ages,as well as the pathological types and malignant degrees.Conclusion:Nested RT PCR express the K 19 mRNA is a sensitive method to detect the micrometastases of ovary cancer.The positive case must have a sufficient and prolonged chemotherapy as early as possible,so as to investigate the effect and to protect from the relapse.
出处 《肿瘤研究与临床》 CAS 2001年第5期310-312,共3页 Cancer Research and Clinic
关键词 角化蛋白 卵巢癌 微转移 聚合酶链反应 血液循环 癌细胞 Keratin 19 mRNA CEA mRNA Micrometastases Ovary cancer PCR
  • 相关文献

参考文献1

二级参考文献6

共引文献24

同被引文献44

  • 1陈鲁,高永良,冯建国.临床早期宫颈癌外周血CK19mRNA的表达[J].肿瘤防治杂志,2005,12(1):56-58. 被引量:5
  • 2程玉瑛 孙立新 等.检测骨髓细胞角化蛋白19在卵巢上皮细胞癌远处转移的价值.妇科肿瘤基础与研究进展[M].济南:济南出版社,2000.43-45.
  • 3余宏昭 谷铣之 等.大肠癌.现代肿瘤学(临床部分)[M].北京:北京医科大学、中国协作医科大学联合出版社,1993.448-457.
  • 4苏正高 刘振华.大肠癌.肿瘤预后学[M].北京:科学文献出版社,1995.512-520.
  • 5李岩.肿瘤临症备要(第3版)[M].北京:人民卫生出版社,1998.302-308.
  • 6Hermanek P,Henson DE, Hutter RVP, et al. International union against cancer. TNM supplement 1993 :a commentary on uniform use [ M ]. Berlin : Springer, 1993:7 - 14.
  • 7Shimoyama M, Yamazaki T, Suda T, et al. Prognostic significance of lateral lymph node in lower rectal cancer:An immunohistochemical study with CAM 52 [ J]. Dis Colon Rectum,2003, 46:333 - 9.
  • 8Benon JR, Querei della Rovere G. Sentinel lymph node in breast cancer [ J ]. Lancet, 1999,354 : 1998.
  • 9Noguchi S, Hiratsuka M, Furukawa H, et al. Detection of gastric cancer in lymph nodes by amplification of Keratin 19 mRNA with reverse transcriptase-polymerase chain teaction [ J ]. Jpn J Cancer Res, 1996,87 ( 6 ) : 650 - 4.
  • 10Levenback CF, Vander Zee AG, Rob L, et al. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008 [ J ]. Gynecol Oncol,2009,5 : 18.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部